Empagliflozin side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Empagliflozin. Common side effects include diabetic ketoacidosis among females, and diabetic ketoacidosis among males.
The phase IV clinical study is created by eHealthMe based on 1,552 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,552 people who take Empagliflozin and have side effects are studied.
What is Empagliflozin?
Empagliflozin has active ingredients of empagliflozin. Currently, eHealthMe is studying from 1,556 Empagliflozin users.
Number of Empagliflozin reports submitted per year:
Empagliflozin side effects by time on the drug *:
Empagliflozin side effects by gender *:
Empagliflozin side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Empagliflozin?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on empagliflozin (the active ingredients of Empagliflozin) and Empagliflozin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Empagliflozin:
- Empagliflozin (1,556 reports)
Common Empagliflozin side effects:
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 151 reports
All Empagliflozin side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ranitidine and Adderall drug interaction - 16 seconds ago
- Levemir and Confusional State - 16 seconds ago
- Indapamide and Moviprep drug interaction - 22 seconds ago
- Inderal La and Soma drug interaction - 25 seconds ago
- Omeprazole and Pancreatitis - 32 seconds ago
- Lucentis and Eye Irritation - 45 seconds ago
- Boron and Prolia drug interaction - 52 seconds ago
- Alcaine and Bactrim drug interaction - 57 seconds ago
- Patanol and Chronic Kidney Disease - 58 seconds ago
- Carmustine and Osteolysis - 58 seconds ago